Polymer selection helps determine whether your modified release (MR) product achieves its target drug release profile. This fact sheet explains the differences between polymers for sustained and modified release dosage forms and how to choose the polymer that best suits your product.
Reformulating an oral solid dosage (OSD) product can be challenging. Here are considerations for making sure you choose a CDMO partner with the right combination of experience, equipment, and technology for your drug product reformulation project.
Navigating regulatory requirements to achieve final approval and product launch can be a complex, time-consuming, and costly endeavor. How do you know your CDMO has the proper experience and capabilities to guide you through the submission process and support your post-approval needs? Here are some questions to ask.